Robert Azelby has been named president and CEO of Alder BioPharmaceuticals (NASDAQ: ALDR). He will also join the Bothell, WA, company’s board of directors. After Azelby starts his new role on June 13, Alder’s interim CEO Paul Cleveland will resume his role as a member of the company’s board. Alder’s founding CEO, Randy Schatzman, resigned […]
Original Article: Alder BioPharmaceuticals Picks Juno’s Robert Azelby for CEO